Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hosking

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Bone|January 13, 2006
Pharmacological therapy of Paget's and other metabolic bone diseasesDavid Hosking
Drugs & Aging|January 6, 2005
Hyperparathyroidism in the elderly patientRebecca Sims, Charanjeit Ubhi, David Hosking
Current Medical Research and Opinion|February 13, 2009
Management of osteoporosis with PTH: treatment and prescription patterns in EuropeDavid Hosking, Carlos Gómez Alonso, Maria Luisa Brandi
Current Medical Research and Opinion|May 4, 2004
Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosisLois E Wehren, David Hosking, Marc C Hochberg
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 13, 2004
A comparison of calcaneal dual-energy X-ray absorptiometry and calcaneal ultrasound for predicting the diagnosis of osteoporosis from hip and spine bone densitometryDerek Pearson, Tahir Masud, Opinder Sahota, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 1, 2005
Self-administered subcutaneous fluid infusion at home in the management of fluid depletion and hypomagnesaemia in gastro-intestinal diseaseAmparo Martínez-Riquelme, Josephine Rawlings, Stephen Morley, et al.
International Journal of Pharmaceutics|January 25, 2006
Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with KyphosisAlan C Perkins, Malcolm Frier, P Elaine Blackshaw, et al.
Clinical Drug Investigation|December 14, 2006
Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -internationalDavid M Reid, David Hosking, David Kendler, et al.
The New England Journal of Medicine|September 2, 2005
Comparison of a single infusion of zoledronic acid with risedronate for Paget's diseaseIan R Reid, Paul Miller, Kenneth Lyles, et al.
Current Medical Research and Opinion|September 19, 2003
Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled studyDavid Hosking, Silvano Adami, Dieter Felsenberg, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bone|January 13, 2006
Pharmacological therapy of Paget's and other metabolic bone diseasesDavid Hosking
Drugs & Aging|January 6, 2005
Hyperparathyroidism in the elderly patientRebecca Sims, Charanjeit Ubhi, David Hosking
Current Medical Research and Opinion|February 13, 2009
Management of osteoporosis with PTH: treatment and prescription patterns in EuropeDavid Hosking, Carlos Gómez Alonso, Maria Luisa Brandi
Current Medical Research and Opinion|May 4, 2004
Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosisLois E Wehren, David Hosking, Marc C Hochberg
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 13, 2004
A comparison of calcaneal dual-energy X-ray absorptiometry and calcaneal ultrasound for predicting the diagnosis of osteoporosis from hip and spine bone densitometryDerek Pearson, Tahir Masud, Opinder Sahota, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 1, 2005
Self-administered subcutaneous fluid infusion at home in the management of fluid depletion and hypomagnesaemia in gastro-intestinal diseaseAmparo Martínez-Riquelme, Josephine Rawlings, Stephen Morley, et al.
International Journal of Pharmaceutics|January 25, 2006
Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with KyphosisAlan C Perkins, Malcolm Frier, P Elaine Blackshaw, et al.
Clinical Drug Investigation|December 14, 2006
Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -internationalDavid M Reid, David Hosking, David Kendler, et al.
The New England Journal of Medicine|September 2, 2005
Comparison of a single infusion of zoledronic acid with risedronate for Paget's diseaseIan R Reid, Paul Miller, Kenneth Lyles, et al.
Current Medical Research and Opinion|September 19, 2003
Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled studyDavid Hosking, Silvano Adami, Dieter Felsenberg, et al.
Pageof 2